Your browser doesn't support javascript.
loading
circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway.
Huang, Yutang; Dai, Yi; Wen, Chunjie; He, Shuai; Shi, Jingjing; Zhao, Dezhang; Wu, Lanxiang; Zhou, Honghao.
Affiliation
  • Huang Y; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Dai Y; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China; Wangjia Community Health Service Center, Chongqing 401120, China.
  • Wen C; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
  • He S; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Shi J; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Zhao D; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Wu L; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China. Electronic address: lxwu@cqmu.edu.cn.
  • Zhou H; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China; Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University, Changsha 410078, China.
Mol Ther Nucleic Acids ; 21: 885-899, 2020 Sep 04.
Article in En | MEDLINE | ID: mdl-32805491

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Mol Ther Nucleic Acids Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Mol Ther Nucleic Acids Year: 2020 Document type: Article Affiliation country: Country of publication: